Impaired endothelial function in young women with premature ovarian failure: Normalization with hormone therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 8, 2004, Pages 3907-3913

  Kalantaridou, Sophia N ^a,d   Naka, Katerina K ^b   Papanikolaou, Evangelos ^a   Kazakos, Nicolaos ^b   Kravariti, Maria ^a   Calis, Karim A ^c   Paraskevaidis, Evangelos A ^a   Sideris, Demetrios A ^b   Tsatsoulis, Agathocles ^a   Chrousos, George P ^c   Michalis, Lampros K ^b  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; GLYCERYL TRINITRATE; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONAL THERAPY; HUMAN; HYPEREMIA; MORTALITY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADULT; BRACHIAL ARTERY; COHORT STUDIES; CONSTRICTION; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; FEMALE; HAND; HUMANS; HYPEREMIA; NITROGLYCERIN; OVARIAN FAILURE, PREMATURE; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 4043056380     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0015     Document Type: Article

References (43)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH 1987 Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105-1110
2. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravinkar V, Sacks FM 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
3. Sack MN, Rader JR, Cannon RO 1994 Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269-270
4. Koh KK, Jin DK, Yang SH, Lee SK, Hwang HY, Kang MH, Kim W, Kim DS, Choi IS, Shin EK 2001 Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation 103:1961-1966
5. Kalantaridou SN, Davis SR, Nelson LM 1998 Premature ovarian failure. Endocrinol Metab Clin North Am 27:989-1006
6. Coulam CB, Adamson SC, Annegers JF 1986 Incidence of premature ovarian failure. Obstet Gynecol 67:604-606
7. Ohta H, Sugimoto I, Masuda A, Komukai S, Suda Y, Makita K, Takamatsu K, Horiguchi F, Nazawa S 1996 Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women. Bone 18:227-231
8. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM 1998 Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 91:12-15
9. Van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD 1996 Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714-718
10. Cooper GS, Sandler DP 1998 Age at natural menopause and mortality. Ann Epidemiol 8:229-235
11. Snowdon DA, Kane RL, Beeson WL, Burke GL, Sprafka JM, Potter J, Iso H, Jacobs Jr DR, Phillips RL 1989 Is early natural menopause a biologic marker of health and aging? Am J Public Health 79:709-714
12. De Kleijn MJJ, van der Schouw YT, Verbeek ALM, Peeters PHM, Banga JD, van der Graaf Y 2002 Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 155:339-345
13. Jacobsen BK, Knutsen SF, Fraser GE 1999 Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 52:303-307
14. Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, Rosner B, Stampfer MJ 1999 Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 159:1061-1066
15. Vita JA, Keany Jr JF 2001 Hormone replacement therapy and endothelial function. The exception that proves the rule? Arterioscler Thromb Vasc Biol 21:1867-1869
16. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:409-502
17. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Deanfield JE 1992 Non-invasive detection of endothelial dysfunction in children and adults at risk for atherosclerosis. Lancet 340:1111-1115
18. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force 2002 Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 39:257-265
19. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
20. Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB 1995 Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Atherioscler Thromb Vasc Biol 15:2094-2100
21. Clarkson TB, Anthony MS, Klein KP 1996 Hormone replacement therapy and coronary artery atherosclerosis: the monkey model. Br J Obstet Gynaecol 103(Suppl 13):53-57
22. Anderson TJ, Uehata A, Gerhard MD, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP, Meredith IT 1995 Close correlation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235-1241
23. Schachinger V, Britten MB, Zeiher AM 2000 Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906
24. Pinto S, Virdis A, Ghiadoni L, Bernini G, Lombardo M, Petraglia F, Genazzani AR, Taddei S, Salvetti A 1997 Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 29:268-273
25. Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennazzani A, Buralli S, Taddei S, Salvetti A 2000 Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 101:2258-2263
26. Grodstein F, Stampfer MJ, Manson JE, Coltitz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH 1996 Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335:453-461
27. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-613
28. Writing Group for the Women's Health Initiative Investigators 2002 Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
29. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators 2003 Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349:523-534
30. Cooper GS 2002 Hormone replacement following early menopause. JAMA 288:2824-2825
31. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, Shawker TH, Merino TJ 1994 Development of luteinized Graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 79:1470-1475
32. Poehlman ET, Toth MJ, Gardner AW 1995 Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123:673-675
33. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM 1997 Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 89:777-779
34. Hamelin BA, Methot J, Arsenault M, Pilote S, Poirier P, Plante S, Bogaty P 2003 Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women. Am J Med 114:599-602
35. Bairey-Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, Hodgson TK, Matthews KA, Pepine CJ, Reis SE, Reichek N, Rogers WJ, Pohost GM, Kelsey SF, Sopko G, WISE Study Group 2003 Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-Sponsored WISE Study. J Am Coll Cardiol 41:413-419
36. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman III WP, Herderick EE, Cornhill JF 1999 Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281:727-735
37. Herrington DM, Espeland MA, Crouse III JR, Robertson J, Riley WA, McBurnie MA, Burke GL 2001 Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol 21:1955-1961
38. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu CR, Liu CH, Azen SP, Estrogen in the Prevention of Atherosclerosis Trial Research Group 2001 Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 135:939-953
39. Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH, Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group 2003 Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 349:535-545
40. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, Milliken EE, Issa JP 1999 Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 43:985-991
41. Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P 1998 Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 104:552-558
42. De Kleijn MJJ, Wilmink HW, Bots ML, Bak AAA, van der Schouw YT, Planellas J, Engelen S, Banga J-D, Grobbee DE 2001 Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women. Atherosclerosis 159:357-365
43. Grodstein F, Clarkson TB, Manson JE 2003 Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 348:645-650